Recent Finacing
Recent Raise
Instylla develops the Hydrogel Embolic System (HES), a catheter-delivered, water‑based liquid that solidifies into an absorbable hydrogel for embolization in peripheral vascular and interventional oncology, conducting pivotal clinical trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
